Skip to content

Genetic and Functional Analysis of Cherubism

Identification of Mutations That Lead to Cherubism in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01630447
Acronym
CBM
Enrollment
600
Registered
2012-06-28
Start date
2009-04-01
Completion date
2030-12-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cherubism

Keywords

cherubism, bone, autoinflammatory disorder, osteoblast, osteoclast, mandible, maxilla

Brief summary

The goal of this research study is to identify genes and regulatory elements on chromosomes that cause cherubism. Together with the investigators collaborators the investigators also study blood samples and tissue samples from patients to learn about the processes that lead to this disorder. The long-term goal of researchers involved in this study is to find mechanisms to slow down bone resorption in cherubism patients.

Detailed description

Cherubism is a very rare bone disorder where bone gets excessively resorbed only in the jaw bones (mandible and maxilla). The resulting cavities in bone fill up with soft fibrous (fibro-osseous) tissues that can expand and push the bony shells apart. Thus the characteristic facial appearance in patients with progressed cherubism. Bone resorption (cherubism lesions) in this disorder occurs always symmetrically in the mandible, the maxilla or in both. This distinguishes cherubism from similar disorders. As cherubism progresses, the lesions can invade the eye sockets (inferior and/or lateral orbital walls) and displace the eye balls and push down the eyelids. As a result the sclera (white of the eye) below the iris becomes visible and patients have an upward gazing appearance (cherubic look) which gave the name to this fibro-proliferative bone disorder. Cherubism typically appears between ages of 2-7 years. It is often diagnosed during dental evaluations. At early stages cherubism is accompanied by lymph node swelling. Proliferation of the fibro-osseous tissue typically stops after puberty and in many the soft tissue in the cherubic bone cavities are replaced by new bone. For this study we will: * Send out study participation kits and consent by phone * Collect a saliva sample from eligible individuals * Obtain information regarding cherubism * Document disorder with photos and doctor's letters * If patients undergo surgery for cherubism we ask to obtain some bone tissue that would otherwise be discarded * Isolate DNA from the saliva sample * Perform genetic analyses of the DNA with the most up-to-date methods available to identify genetic variations * Study in the laboratory why the genetic variations cause the disorder

Interventions

None listed

Sponsors

UConn Health
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* cherubism; unaffected individuals only if part of a participating cherubism family

Exclusion criteria

* no cherubism unaffected individuals only as part of a participating cherubism family

Design outcomes

Primary

MeasureTime frameDescription
Identification of genetic elementsat time of identificationThe goal is to identify relevant genes or genetic elements that cause the disease or contribute to the disease progression and severity.

Countries

United States

Contacts

CONTACTErnst J Reichenberger, PhD
reichenberger@uchc.edu860-679-2062
PRINCIPAL_INVESTIGATORErnst J Reichenberger, PhD

UConn Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026